Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

EXPAREL Administered by Infiltration Into the TAP for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries

ClinicalTrials.gov ID: NCT01919190

Public ClinicalTrials.gov record NCT01919190. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 5:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Assessing the Impact of EXPAREL(R) on Opioid Use and Patient Reported Outcomes When Administered by Infiltration Into the Transversus Abdominis Plane (TAP) Under Ultrasound Guidance for Prolonged Postsurgical Analgesia in Lower Abdominal Surgeries

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this prospective, blinded assessor, randomized trial is to assess opioid use and patient-reported outcomes of EXPAREL as a foundation in postsurgical pain therapy in Transversus Abdominis Plane (TAP) infiltration in lower abdominal surgical procedures.

Study identification

NCT ID
NCT01919190
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pacira Pharmaceuticals, Inc
Industry
Enrollment
67 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2013 (Type not available)
Primary completion
Dec 2013 (Actual)
Completion
Feb 2014 (Actual)
Last update posted
Jul 2, 2021

2013 – 2014

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
Florida Hospital Winter Park Florida 32792 —
Memorial Health University Medical Center Savannah Georgia 31404 —
Northwestern University Chicago Illinois 60208 —
University of Louisville Louisville Kentucky 40202 —
Berkshire Medical Center Pittsfield Massachusetts 01210 —
University of Minnesota Minneapolis Minnesota 55404 —
Montefiore Medical Center The Bronx New York 10467 —
Duke University Durham North Carolina 27705 —
Fairview Hospital Cleveland Ohio 44111 —
The Ohio State University Columbus Ohio 43210 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
UPMC St. Margaret's Hospital Pittsburgh Pennsylvania 15215 —
St. John Hospital Houston Texas 77081 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01919190, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 2, 2021 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01919190 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →